Estamos no ar no !
Saiba mais
HGEN
Humanigen
Deslistada
HGEN foi retirado da bolsa em 25 de julho de 2023.
Sobre: Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.
Funcionários: 6
Notícias
Positiva
Neutra
Negativa
Sentimento
3 meses
Positiva
0%
Neutra
0%
Negativa
0%
Não recebemos notícias recentes sobre HGEN
Gráficos de preços implementados com Lightweight Charts™